Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: Ready for prime time

Lunenburg, C.A.T.C.; Henricks, L.M.; Guchelaar, H.J.; Swen, J.J.; Deenen, M.J.; Schellens, J.H.M.; Gelderblom, H. (2016)

Article / Letter to editor

• Dihydropyrimidine dehydrogenase
• DPYD
• Fluoropyrimidines
• Capecitabine
• 5-Fluorouracil
• Pharmacogenomics
• Individualised medicine

• All authors: Lunenburg, C.A.T.C.; Henricks, L.M.; Guchelaar, H.J.; Swen, J.J.; Deenen, M.J.; Schellens, J.H.M.; Gelderblom, H.
• Date: 2016-02-28
• Journal: European Journal of Cancer
• Volume: 54
• Pages: 40 - 48
• DOI: doi:10.1016/j.ejca.2015.11.008